NCT01079988: Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence |
|
|
| Completed | 4 | 41 | Canada | Cyclosporins, Retinoids, Systemic corticosteroids, Methotrexate, Systemic corticosteroids/methotrexate | Merck KGaA, Darmstadt, Germany | Psoriasis | 12/04 | 04/05 | | |
NCT00512187: Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial |
|
|
| Completed | 4 | | Europe | low calorie diet | Universita di Verona | Chronic Plaque Psoriasis, Obesity | | 08/07 | | |
